BACKGROUND AND PURPOSE: Stroke is a major healthcare issue worldwide with an incidence comparable to coronary events, highlighting the importance of understanding risk factors for stroke and subsequent mortality. METHODS: In the present study, we determined long-term (all-cause) mortality in 545 patients with ischemic stroke compared with a cohort of 330 age-matched healthy control subjects followed up for a median of 7.4 years. We assessed the effect of selected demographic, clinical, biochemical, hematologic, and hemostatic factors on mortality in patients with ischemic stroke. Stroke subtype was classified according to the Oxfordshire Community Stroke Project criteria. Patients who died 30 days or less after the acute event (n=32) were excluded from analyses because this outcome is considered to be directly attributable to the acute event. RESULTS: Patients with ischemic stroke were at more than 3-fold increased risk of death compared with the age-matched control cohort. In multivariate analyses, age, stroke subtype, atrial fibrillation, and previous stroke/transient ischemic attack were predictive of mortality in patients with ischemic stroke. Albumin and creatinine and the hemostatic factors von Willebrand factor and beta-thromboglobulin were also predictive of mortality in patients with ischemic stroke after accounting for demographic and clinical variables. CONCLUSIONS: The results indicate that subjects with acute ischemic stroke are at increased risk of all-cause mortality. Advancing age, large-vessel stroke, atrial fibrillation, and previous stroke/transient ischemic attack predict mortality; and analysis of albumin, creatinine, von Willebrand factor, and beta-thromboglobulin will aid in the identification of patients at increased risk of death after stroke.
BACKGROUND AND PURPOSE:Stroke is a major healthcare issue worldwide with an incidence comparable to coronary events, highlighting the importance of understanding risk factors for stroke and subsequent mortality. METHODS: In the present study, we determined long-term (all-cause) mortality in 545 patients with ischemic stroke compared with a cohort of 330 age-matched healthy control subjects followed up for a median of 7.4 years. We assessed the effect of selected demographic, clinical, biochemical, hematologic, and hemostatic factors on mortality in patients with ischemic stroke. Stroke subtype was classified according to the Oxfordshire Community Stroke Project criteria. Patients who died 30 days or less after the acute event (n=32) were excluded from analyses because this outcome is considered to be directly attributable to the acute event. RESULTS:Patients with ischemic stroke were at more than 3-fold increased risk of death compared with the age-matched control cohort. In multivariate analyses, age, stroke subtype, atrial fibrillation, and previous stroke/transient ischemic attack were predictive of mortality in patients with ischemic stroke. Albumin and creatinine and the hemostatic factors von Willebrand factor and beta-thromboglobulin were also predictive of mortality in patients with ischemic stroke after accounting for demographic and clinical variables. CONCLUSIONS: The results indicate that subjects with acute ischemic stroke are at increased risk of all-cause mortality. Advancing age, large-vessel stroke, atrial fibrillation, and previous stroke/transient ischemic attack predict mortality; and analysis of albumin, creatinine, von Willebrand factor, and beta-thromboglobulin will aid in the identification of patients at increased risk of death after stroke.
Authors: Elizabeth Mostofsky; Gregory A Wellenius; Amit Noheria; Emily B Levitan; Mary R Burger; Gottfried Schlaug; Murray A Mittleman Journal: Cerebrovasc Dis Date: 2009-05-20 Impact factor: 2.762
Authors: Christina L Bell; Andrea LaCroix; Kamal Masaki; Erinn M Hade; Todd Manini; W Jerry Mysiw; Jess David Curb; Sylvia Wassertheil-Smoller Journal: J Am Geriatr Soc Date: 2013-07-19 Impact factor: 5.562
Authors: R F Gottesman; C Cummiskey; L Chambless; K K Wu; N Aleksic; A R Folsom; A R Sharrett Journal: Cerebrovasc Dis Date: 2009-10-16 Impact factor: 2.762
Authors: Nicole Lüneburg; Wolfgang Lieb; Tanja Zeller; Ming-Huei Chen; Renke Maas; Angela M Carter; Vanessa Xanthakis; Nicole L Glazer; Edzard Schwedhelm; Sudha Seshadri; Mohammad Arfan Ikram; William T Longstreth; Myriam Fornage; Inke R König; Christina Loley; Francisco M Ojeda; Arne Schillert; Thomas J Wang; Heinrich Sticht; Anja Kittel; Jörg König; Emelia J Benjamin; Lisa M Sullivan; Isabel Bernges; Maike Anderssohn; Andreas Ziegler; Christian Gieger; Thomas Illig; Christa Meisinger; H-Erich Wichmann; Philipp S Wild; Heribert Schunkert; Bruce M Psaty; Kerri L Wiggins; Susan R Heckbert; Nicholas Smith; Karl Lackner; Kathryn L Lunetta; Stefan Blankenberg; Jeanette Erdmann; Thomas Munzel; Peter J Grant; Ramachandran S Vasan; Rainer H Böger Journal: Circ Cardiovasc Genet Date: 2014-09-21
Authors: Gretchen N Neigh; Christina L Nemeth; Sean D Kelly; Emily E Hardy; Chase Bourke; Zachary N Stowe; Michael J Owens Journal: Physiol Behav Date: 2016-07-13